Antibacterial Agents

Kane Biotech identifies lead candidate for coating central venous catheters

Published in Blood Weekly, September 28th, 2006

Kane Biotech, Inc., (KNE), a biotechnology company engaged in the development of products to prevent and disperse bacterial biofilms, reported it has identified a promising coating product for reducing infections associated with central venous catheters (CVCs).

This is the result of an intensive internal screening study designed to recognize promising candidates, and ultimately identify a lead candidate for further preclinical and clinical development.

The coating product, identified as KBI-4258, builds upon Kane Biotech's proprietary dispersinB technology. DispersinB is a novel enzyme responsible for inhibition and dispersal of bacterial biofilms,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2006-09-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry